A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa
Status:
Terminated
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative efficacy and safety of the test
formulation of ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension (Par
Pharmaceutical Companies, Inc.) to the already-marketed formulation CIPRODEX® (ciprofloxacin
0.3%/dexamethasone 0.1%) sterile otic suspension (Alcon) in the treatment of acute bacterial
otitis externa.